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Background: Depression is highly prevalent in the working population and is associated with significant loss of workdays;
however, access to evidence-based treatment is limited.
Objective: This study evaluated the effectiveness of a Web-based intervention in reducing mild to moderate depression and
sickness absence.
Methods: In an open-label randomized controlled trial, participants were recruited from a large-scale statutory health insurance
and were assigned to two groups. The intervention group had access to a 12 week Web-based program consisting of structured
interactive sessions and therapist support upon request. The wait-list control group had access to unguided Web-based
psycho-education. Depressive symptoms were self-assessed at baseline, post-treatment, and follow-up (12 weeks after treatment)
using the Patient Health Questionnaire (PHQ-9) and Beck Depression Inventory (BDI-II) as primary outcome measures. Data on
sickness absence was retrieved from health insurance records. Intention-to-treat (ITT) analysis and per-protocol (PP) analysis
were performed.
Results: Of the 180 participants who were randomized, 88 completed the post-assessment (retention rate: 48.8%, 88/180). ITT
analysis showed a significant between-group difference in depressive symptoms during post-treatment in favor of the intervention
group, corresponding to a moderate effect size (PHQ-9: d=0.55, 95% CI 0.25-0.85, P<.001, and BDI-II: d=0.41, CI 0.11-0.70,
P=.004). PP analysis partially supported this result, but showed a non-significant effect on one primary outcome (PHQ-9: d=0.61,
95% CI 0.15-1.07, P=.04, and BDI-II: d=0.25 95% CI −0.18 to 0.65, P=.37). Analysis of clinical significance using reliable
change index revealed that significantly more participants who used the Web-based intervention (63%, 63/100) responded to the
treatment versus the control group (33%, 27/80; P<.001). The number needed to treat (NNT) was 4.08. Within both groups, there
was a reduction in work absence frequency (IG: −67.23%, P<.001, CG: −82.61%, P<.001), but no statistical difference in sickness
absence between groups was found (P=.07).
Conclusions: The Web-based intervention was effective in reducing depressive symptoms among adults with sickness absence.
As this trial achieved a lower power than calculated, its results should be replicated in a larger sample. Further validation of health
insurance records as an outcome measure for eHealth trials is needed.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 02446836;
http://www.isrctn.com/ISRCTN02446836 (Archived by WebCite at http://www.webcitation.org/6jx4SObnw)
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Introduction
Depression is highly prevalent in the working population [1].
It is estimated that over the course of one year, up to 26.7% of
adults experience depressive symptoms and about 8.9% fulfill
all criteria for a depressive disorder [2]. The resulting
impairment and functional disability poses a substantial burden
for the affected individual as well as the economy. Depressed
employees have higher health care costs than those without
depression [3,4], which in Europe contribute to a total estimated
cost of 118 billion Euros per year [5].
Depression is linked to a high loss of work days [6]. In Germany,
depression is a major driver of sickness absence and produces
higher durations of sickness absence than other diagnoses of
mental disorders [7]. When employees return to work after a
depressive episode, distress often remains and performance is
reduced [8,9]. Therefore, maintaining work capacity should be
an important goal of clinical interventions. However, health
promotion interventions targeting occupational health in
employees with depression have been developed with mixed
results [10-13]. Access to treatment remains limited, and the
existing personal and structural barriers prevent those affected
by depression from seeking timely, evidence-based help [14-16].
Web-based interventions are a promising tool to overcome the
treatment gap in depression [17]. While generally using similar
techniques as face-to-face therapy, such interventions are
commonly delivered through websites and allow participants
to access content at any time and work through lessons at their
own pace. Web-based interventions vary in the level of therapist
support [18], from entirely self-help to guided formats including
regular therapist contact (eg, feedback via email). The
advantages of Web-based interventions are their accessibility,
a low threshold for help-seeking, relative anonymity, the
patients’ active role in (guided) self-help, and their low costs.
However, in studies comparing Web-based interventions to
usual care, risks associated with the dissemination of Web-based
interventions have been reported as well [19,20]. Among the
working population, Web-based interventions could especially
benefit those who do not want to seek regular treatment because
of negative perceptions of mental ill-health at the workplace.
The effectiveness of Web-based interventions in reducing
depressive symptoms has been demonstrated repeatedly, but
effect sizes vary considerably across studies [21-23]. For
example, in the 19 studies that were included in the
meta-analysis by Richards and Richardson [21], depression
improvement in comparison with a control group ranged from
no effect (d=−0.03) to strong effects (d=1.43). This
heterogeneity makes it necessary to evaluate the interventions
separately. Methodologically, weak control groups (eg, wait-list
control instead of active control groups) and failure to employ
intention-to-treat principles lead to an overestimation of the
treatment effect [24]. Web-based interventions for depression
have been studied among different clinical populations in
Germany [25-29] but, to the best of our knowledge, no studies
have yet focused on a Web-based intervention among a
population with sick leave due to depression.
Participant self-reports are the primary outcome measure of
eHealth trials. However, the lack of independent outcome
assessments and the sole reliance on self-report measures limits
this evolving field. For example, a report on the methodological
quality of randomized controlled trials of Web-based
interventions concluded that an increased use of independent
outcome measurements is needed to improve the validity of
efficacy studies [24]. To date, few studies employ independent
outcomes and such attempts are limited to observer ratings of
symptoms and do not extend to objective behavioral
measurement of work absenteeism [30-32]. The lack of objective
sickness absence measurements in research on Web-based
interventions is surprising because sickness absence is frequently
used as an integrated measure of health in other fields [33].
This study examined the effectiveness of a guided Web-based
intervention in reducing depression and sickness absence among
a high-risk population using both self-assessed depression and
sickness absence assessments from health insurance records.
We hypothesized that the Web-based intervention would be
more effective in reducing depressive symptoms and sickness
absence than the control group.
Methods
Study Design
This was a two-armed open-label randomized controlled trial.
Participants were randomly assigned to either the intervention
group (IG), with access to the guided Web-based intervention,
or the wait-list control group (CG), with access to unguided
Web-based psycho-education.
We used a computerized block randomization procedure
(allocation ratio 1:1, block size 10). The researcher conducting
the randomization had no information about the participants
apart from their 6-digit codes and did not participate in the
enrollment and assignment of the participants to study groups,
which was handled by two different researchers. Outcome
variables were assessed at baseline (T0) and 12 weeks after
randomization (post-treatment, T1). In addition, a follow-up
measurement was assessed 24 weeks after randomization (12
weeks after treatment, T2). Sample size calculation was based
on expected between-group differences at follow-up. G*Power
was used for sample size calculation [34]. First, we assumed a
power of 0.80, an alpha level of 0.05, and a small to medium
effect size (d=0.3), which results in N=357 to perform a
two-sided t test for differences between two independent means.
Second, adding 20% attrition rate at inclusion, post-assessment,
and follow-up, we calculated that N=608 participants needed
to be enrolled.
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The study was approved by the ethical review board at Leuphana
University of Lüneburg. The study was registered retrospectively
on February 1, 2013, under the International Standard
Randomized Controlled Trial Number ISRCTN02446836;
http://www.controlled-trials.com/ISRCTN02446836. Despite
retrospective registration, no participants were enrolled before
registration.
Recruitment
Participants were recruited from a large-scale German statutory
health insurance between January 2013 and April 2014, with
the first participant enrolled in February 2013. We recruited
members from Kaufmännische Krankenkasse (KKH), a statutory
health insurance company with about 1.8 million members
nationwide. First, to identify participants who were at high risk
for sick leave due to depression, insurance members were
screened for previous diagnosis of depression (International
Classification of Disease codes F32.0, F32.1, F33.0, F33.1, and
F34.1), previous sickness absence due to depression, and current
sickness absence. Second, the study team sent an invitation
letter to all positively screened insurance members along with
study information, the informed consent form (see Multimedia
Appendix 1), and a 6-digit code to login into the platform.
Adults with a previous episode of mild to moderate depression
(International Classification of Disease codes F32.0, F32.1,
F33.0, F33.1) or dysthymia (F34.1) were included to avoid
giving less intensive treatment than necessary. Before
registration on the platform, a screening for exclusion criteria
was performed. Participants with a score of ≥20 on the Patient
Health Questionnaire (PHQ-9), indicating severe depression,
were excluded. A second exclusion criterion was suicidality as
measured by one item on the presence of suicidal thoughts. All
participants had unrestricted access to treatment as usual during
the study period, including access to the treatments and services
which are typically available for depression in the German health
care system (eg, psychotherapy and medication).
Intervention
The Web-based intervention “HelpID” is a 12-week, Web-based
program based on cognitive-behavioral therapy, awareness
training, and systemic counseling. The program was structured
into 12 weekly sessions. Each lasted 30 to 45 minutes and
included interactive elements, videos, and audios that explained
depression-related themes (eg, symptoms and course) as well
as graphs, illustrations, exercises, and guidance for awareness
and relaxation. Each session was available one week after
completing the prior session. Participants received weekly
reminder emails when a new session was available. The program
had a guided format with therapist contact upon request, that
is, psychologists (bachelor level or higher) trained in the
intervention approach provided feedback via email or telephone.
The intervention was developed by a team of clinical
psychologists headed by Dr Despina Lion, a clinical
psychologist and therapist with extensive experience in systemic
counseling, cognitive-behavioral therapy, and neurological
psychology. It is accessible online [35] (see Multimedia
Appendix 2). Since July 2016, the copyright of “HelpID” is
owned by IVPNetworks GmbH, a private integrated care
company. The intervention is commercially available to single
users and is included in health care plans of statutory health
insurances.
The intervention’s psychological approach includes
cognitive-behavioral therapy, mindfulness training, and systemic
counseling. During the development process, current research
evidence on the respective therapies was used as the basis, and
special emphasis was placed on a “person-based” approach,
focusing on the perspectives of the people who would use the
intervention. Cognitive-behavioral therapy is the most
extensively researched psychological treatment approach in
Web-based interventions [36]. From cognitive-behavioral
therapy, the intervention used elements of cognitive
restructuring, with an emphasis on dealing with negative moods
and automatic thoughts, as well as exercises for behavioral
activation. Mindfulness training has been used increasingly in
psychotherapy over the past years. It was shown to be effective
for depressive symptoms and can be adapted to online formats
[37,38]. The intervention module on mindfulness engages the
user in exercises to observe the self and to practice mindfulness
in daily situations. Systemic counseling is a therapeutic approach
that highlights the social context surrounding the individual and
its resources [39]. Specifically, systemic questioning techniques
and instructions were employed to make use of the participants’
social support. Systemic principles were presented in specific
weekly sessions, while homework exercises on systemic therapy
encouraged the participants to adopt a systemic viewpoint and
behavior change in their everyday interactions.
Control Group
The control group was a wait-list plus psycho-education
condition. During the 12-week study period, participants had
access to text-based information on the nature of depression
and its symptoms and treatment. The psycho-education content
was developed by a team of trained psychologists (bachelor
degree or higher) and was based upon scientific literature on
depression (eg, the German S3-Guideline) [40]. This type of
control condition was chosen because more active control groups
(ie, psycho-education) are considered to be more
methodologically valid than passive control groups (ie, wait-list
conditions) [24]. There is evidence that psycho-education can
reduce depressive symptoms and serve as an initial treatment
in primary care [41]. The control group did not have access to
therapist guidance. Participants were eligible to access the
intervention after study completion, if they requested access.
Outcomes
The primary outcomes were self-assessed depressive symptoms
with the Patient Health Questionnaire (PHQ-9) and the Beck
Depression Inventory (BDI II). The PHQ-9 measured the
severity of depressive symptoms over the preceding 2 weeks,
resulting in a score between 0 to 27 points with higher values
indicating more severe depression [42,43]. The PHQ-9 was
shown to have good reliability and construct validity [42]. The
BDI II uses 21 items to measure depression severity [44,45].
The BDI II showed good psychometric properties in
German-speaking samples in regard to internal consistency,
retest-reliability, and construct validity [46]. As a secondary
outcome, quality of life was assessed using the Manchester
Short Assessment of Quality of Life (MANSA) [47]—a 12-item
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scale rating the participants’ satisfaction with different life
domains. The MANSA has been validated in a Swedish sample
and showed satisfactory internal consistency and construct
validity [48]. User satisfaction was measured at post-assessment
using the item “Overall, how satisfied are you with the
program?” with four answer options: 1=very good, 2=good,
3=satisfactory, and 4=poor.
Information on work absenteeism was retrieved from health
insurance records. In the German health care system, such
standardized health data is collected routinely. Its primary
purpose is cost reimbursement and quality assurance, but it can
be made available for secondary analysis. Due to the routine
data collection, health insurance records are assumed to have
high ecological validity. We matched health insurance records
from KKH health insurance with participants’ data using a
6-digit participant code as identifier. The code was generated
for each positively screened insurance member and was also
used for registration on the study platform. We analyzed sickness
absence data that covered the 90 days before randomization
(baseline) and 90 days after intervention (post-assessment).
Three sickness absence measures were constructed according
to Hensing et al [33]. First, the number of persons who were
absent at least once, second, absence frequency as the number
of times a person was absent during the 90 day period irrelevant
of duration, and third, absence duration as the total number of
absence days during the 90 day period. Sickness absence data
was not diagnosis-specific.
Statistical Analysis
Statistical analysis was performed on an intention-to-treat (ITT)
basis according to the recommendations in the CONSORT
statement [49] and its adaption for eHealth trials [50] (see
Multimedia Appendix 3). Missing data at post-treatment was
imputed using the Markov Chain Monte Carlo multiple
imputation (missing data module in IBM SPSS version 22),
where 10 estimations per missing value were specified and,
besides the outcome variables, group assignment was included
as an additional variable. Under the assumption that data is
missing at random, multiple imputation was considered suitable
to produce more precise estimates of the true intervention effect
than other imputation methods, that is, last observation carried
forward [51]. In addition, per-protocol (PP) analysis was
performed to examine the robustness and sensitivity of the
findings when including only participants who completed the
post-assessment. t tests were used to determine differences in
baseline characteristics and for within-group differences. The
difference in the intervention outcomes between the intervention
group and the control group at post-treatment was estimated
using analysis of covariance (ANCOVA) with baseline scores
as the covariate. Cohen d was calculated as a measure of the
effect size, using pooled standard deviations [52]. For the
between-group effect sizes, Cohen d was computed from the
mean differences.
To assess clinical significance on an individual level, the reliable
change index (RCI) was computed for the PHQ-9 [53]. Cronbach
alpha=.89 from Kroenke et al [42] was used as an estimate of
the reliability of the PHQ-9, along with pre-treatment standard
deviations from the current study. Participants were classified
as “responders” if they displayed a reliable positive change, or
as “deteriorated” if they displayed a negative change on the
RCI. A reliable positive change corresponds to less than −1.96
on the RCI and a change of PHQ-9 points to greater than −4.05.
A reliable negative change corresponds to less than −1.96 on
the RCI and a change in PHQ-9 points to greater than 4.05.
Finally, the number needed to treat (NNT) [54] was computed.
All analysis was performed using Stata 13. The reported P
values are two sided and in the 95% CI.
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Figure 1. Study flowchart.
Results
Participant Characteristics
Figure 1 shows the flow of participants through the study. The
complete pool of insurance members was screened, which
resulted in 3929 positively screened insurance members who
were subsequently invited to participate. Of those, 180
responded, met the inclusion criteria, provided informed consent,
and were randomized. Of the 180 participants, 88 completed
the post-assessment after 12 weeks (retention rate: 48.8%,
88/180), and 58 completed the follow-up assessment after 24
weeks (retention rate: 32.2%, 58/180). To estimate achieved
power, a post-hoc power analysis was conducted. This revealed
that with the sample of 180 participants, the achieved power to
detect an effect of d=0.3 was 0.51.
Baseline characteristics between participants who completed
the post-assessments and those who were lost to follow-up were
tested for differences. Older participants (PHQ at T1: P=.02,
BDI at T2: P=.03) and participants with higher education (PHQ
at T1: P=.03, BDI at T2: P=.04) were more likely to complete
the post-assessment on the primary outcome and the follow-up
assessment. Participants who were not in psychotherapy during
study enrollment were more likely to complete post-assessment
on one of the primary outcomes (BDI at T1: P=.04) and the
follow-up assessment (BDI at T2: P=.04) as compared with
participants who were on a waiting list or in psychotherapy at
enrollment. No other relevant differences between those who
completed the post-assessments and those who were lost to
follow-up were found.
Table 1 shows the participant characteristics at baseline.
Participants had an average age of 48 years and were
predominantly female (68%). The majority were married or had
a partner (56%) and had completed secondary education or
higher (85%). About half of the sample was working full-time
(51%) and another 27% were working part time, while 20% of
those working had an executive position. About one-fifth (21%)
were not working. The majority had experienced a previous
depressive episode (51%) or reported to have chronic depression
(30%). During study enrollment, half of the participants were
prescribed with depression medication (50%), 26% were in
psychotherapy, and 13% were on a psychotherapy waiting list.
Of the total number of enrolled participants, 43% had a sick
leave certificate at the time. The mean baseline depressive
symptoms in the sample were 11.10 points on the PHQ-9
(SD=4.45), indicating moderate depression. No clinically
relevant differences in terms of any baseline characteristics were
found, and we concluded that randomization was successful.
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Table 1. Participant characteristics at baseline.
P valueTotal sampleControl groupIntervention groupCharacteristic
n=180n=80n=100a
.1511.10 (4.45)10.56 (4.53)11.53 (4.35)PHQ-9 Score, mean (SD)
.3147.74 (10.92)48.66 (11.59)47.01 (10.36)Age, mean (SD)
Gender, n (%)
.4557 (31.7)23 (28.7)34 (34.0)Male
123 (68.3)57 (71.3)66 (66.0)Female
Relationship, n (%)
.9342 (23.3)18 (22.5)24 (24.0)Single
102 (56.7)46 (57.5)56 (56.0)Married/Partner
29 (16.1)14 (17.5)15 (15.0)Divorced/Separated
7 (3.9)2 (2.5)5 (5.0)Widowed
Education, n (%)
.3826 (14.6)13 (16.2)13 (13.3)Low
105 (59.0)42 (52.5)63 (64.3)Middle
47 (26.4)25 (31.3)22 (22.4)High
Employment, n (%)
.4190 (51.4)39 (50.6)51 (52.0)Full-time
48 (27.4)18 (23.4)30 (30.6)Part-time
37 (21.2)20 (26.0)17 (17.3)Not working
Executive position, n (%)
.4833 (20.0)13 (17.6)20 (22.0)Yes
132 (80.0)61 (82.4)71 (78.0)No
Previous depressionb , n (%)
.5332 (17.9)14 (17.7)18 (18.0)None
92 (51.4)38 (48.1)54 (54.0)Episodic
55 (30.7)27 (34.2)28 (28.0)Chronic
Depression medication, n (%)
.3389 (49.7)36 (45.6)53 (53.0)Yes
90 (50.3)43 (54.4)47 (47.0)No
In psychotherapy, n (%)
.1546 (25.7)16 (20.3)30 (30.0)Yes
109 (60.9)52 (65.8)57 (57.0)No
24 (13.4)11 (13.9)13 (13.0)Waiting List
aAll values (except for P values) are mean (SD) or n (%).
bOriginal item: “Did you have these symptoms for the first time?” Answer options: 1. “Yes,” 2. “No; I had one or multiple episodes,” 3. “No; the
symptoms last for several years.”
Intervention Effectiveness
Table 2 shows the mean scores, standard deviations for the
intervention outcomes at baseline and at post-assessment, effect
sizes, and statistical significance, based on the intention-to-treat
sample (imputed data). A significant between-group difference
in favor of the intervention group was found for the PHQ-9
(F1,179=15.06, P<.001), which corresponds to a medium effect
size (d=0.55, CI 0.25-0.85). For those in BDI-II, a significant
between-group difference at post-treatment was found
(F1,179=8.69, P=.004), which corresponds to a moderate effect
size (d=0.40, CI 0.10-0.70).
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Table 2. Means, standard deviations (SD), effect sizes, and statistical significance for intervention outcomes based on intention-to-treat sample (imputed
data).
Statistical SignificancebEffect SizeaMean (SD)Outcome
P valueF ValueCohen d (95% CI)Difference (T0−T1)Post-assessment (T1)Baseline (T0)
PHQ-9
<.00115.060.55 (0.25-0.85)−5.02 (3.62)6.51 (2.87)11.53 (4.35)Intervention
−2.80 (4.42)7.76 (3.63)10.56 (4.53)Control
BDI-II
.0048.690.41 (0.11-0.70)−6.17 (6.39)13.55 (6.46)20.07 (7.99)Intervention




0.14 (0.71)3.50 (0.67)3.27 (0.72)Intervention
0.22 (0.55)3.44 (0.70)3.30 (0.85)Control
aBetween-group effect size from mean differences.
bBased on ANCOVA controlling for baseline scores (T0).
In addition, both the intervention and the control group showed
reductions in depressive symptoms as measured by within-group
changes from baseline to post-assessment. In the intervention
group, a mean reduction of 5 points on the PHQ-9 was found
(t99=14.28, P<.001), which corresponds to a large within-group
effect size (d=1.42, CI 1.14-1.71). In the control group, a mean
reduction of 2.79 points was found (t79=5.82, P<.001),
corresponding to a moderate effect size (d=0.65, CI 0.41-.89).
In the per-protocol analysis, we tested for differences in PHQ-9
scores between intervention completers and noncompleters at
post-assessment. No significant difference was found (t178=−.28,
P=.78). Table 3 presents the results of the per-protocol analysis.
For the PHQ-9, a significant between-group difference in favor
of the intervention group was found among completers (PHQ-9:
F1,77=8.98, P=.04), corresponding to a moderate effect size
(d=0.61, CI 0.15-1.07). The mean PHQ-9 scores among
completers were reduced by 5.70 points in the intervention
group and by 2.24 points in the control group—this corresponds
to a large effect size (d=1.72, CI 1.23-2.22) and a moderate
effect size (d=0.49, CI 0.14-0.82) for within-group changes,
respectively. For the BDI-II, the between-group effect failed to
reach statistical significance in the per-protocol analysis
(F1,77=0.81, P=.37, d=0.25, CI −0.18 to 0.65). BDI-II
within-group changes were significant in the intervention group
(t43=3.68, P<.001) and the control group (t42=4.70, P<.001).
Table 3. Means, standard deviations (SD), effect sizes, and statistical significance for intervention outcomes based on per-protocol sample (nonimputed
data).
Statistical SignificancebEffect SizeaMean (SD)Outcome
P valueF valueCohen d (95% CI)Difference (T0−T1)Post-assessment (T1)Baseline (T0)
PHQ-9
.048.980.61 (0.15-1.07)−5.03 (3.29)6.50 (3.85)11.53 (4.35)Intervention




−5.21 (7.59)14.86 (8.05)20.07 (7.99)Intervention




0.25 (0.64)3.52 (0.86)3.27 (0.72)Intervention
0.12 (0.79)3.42 (0.83)3.30 (0.85)Control
aBetween-group effect size from mean differences.
bBased on ANCOVA controlling for baseline scores (T0).
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Table 4. Work absence indicators at baseline and at post-assessment for 160 participants.
P valueDifference (%)Post-assessment (T1)Baseline (T0)aIndicator
Absence at least once, n (%)
<.001−50 (−66.67)25 (28.41)75 (85.22)Intervention
<.001−46 (−79.31)12 (16.67)58 (80.55)Control
Absence frequency, mean (SD)
<.001−0.80 (−67.23)0.39 (0.08)1.19 (0.09)Intervention
<.001−0.95 (−82.61)0.20 (0.06)1.15 (0.10)Control
Absence duration, mean (SD)
.79−0.95 (−3.71)24.65 (3.80)25.60 (2.03)Intervention
.34−3.65 (−13.18)24.04 (4.36)27.69 (2.37)Control
aBaseline and post-assessment cover a period of 90 days each.
Treatment Response
In the intervention group, 63% (63/100) of the participants
showed a reliable symptom change from baseline to
post-intervention and were thus classified as responders. In the
control group, 33% (27/80) were classified as responders. The
difference in reliable symptom change between intervention
and control group was significant (t178=3.39, P<.001). This
resulted in a NNT of 4.08. One participant in the intervention
group experienced symptom deterioration, and five participants
in the control group experienced symptom deterioration.
Sickness Absence
Information on sickness absenteeism was available for 160
participants (Intervention group: n=88, control group: n=72).
For 20 participants, sickness absenteeism could not be retrieved
from insurance records, and therefore the data from these
participants was unavailable.
Table 4 shows persons who were absent at least once, with
absence frequency and absence duration at baseline and at
post-assessment. The majority of the participants were absent
at least once during the baseline period: IV: 85% (77/85), CG:
80% (58/72). Overall, significantly fewer participants were
absent at least once during post-assessment (IV: 28%, CG: 16%).
The within-group absence reductions were significant (IV:
t87=6.54, P<.001, CG: t71=6.17, P<.001).
Regarding absence frequency, participants in the intervention
group were absent on average 1.2 times at baseline and 0.4 times
at post-assessment. In the control group, participants were absent
1.2 times at baseline and 0.2 times at post-assessment. The
within-group reductions in absence frequency were significant
(IV: t87=7.49, P<.001, CG: t71=8.59, P<.001).
Similarly, high absence durations at both baseline and
post-assessment were found. From the 90 days examined at
each time point, participants in the intervention group were
absent from work 26 days at baseline and 25 days at
post-assessment. In the control group, participants were absent
28 days at baseline and 24 days at post-assessment. However,
there were no significant differences in absence duration from
baseline to post-assessment (IV: t87=.26, P=.79, CG: t71=.95,
P=.34). For all three measurements, the between-group
differences at post-assessment failed to reach statistical
significance (absence at least once: F1,159=.80, P=.37, absence
frequency: F1,159=3.24, P=.07, absence duration: F1,159=.02,
P=.88).
Secondary Outcome
No significant difference in quality of life as measured by
MANSA was found (F1,169=.71, P=.40, d=0.13, CI −0.21 to
0.41).
Long-term effect
No significant between-group difference for BDI-II depression
scores at 24-week follow-up was found (F1,85=.81, P=.33).
However, significant within-group changes were sustained for
both the intervention and the control group. In the intervention
group, there was a mean reduction from baseline to follow-up
assessment of 5.46 points on the BDI-II (t99=6.81, P<.001),
which corresponds to a moderate effect size (d=0.68, CI
0.46-0.90). In the control group, there was a mean reduction of
4.69 points (t79=4.37, P<.001), corresponding to a small effect
size (d=0.48, CI 0.26-0.72).
User Satisfaction
87 participants completed the user satisfaction survey at
post-assessment. In the intervention group, 13.6% (6/44) rated
the program overall as very good, 68.2% (30/44) as good, and
18.2% (8/44) as satisfactory. In the control group, 4.6% (2/43)
rated the program as very good, 37.2% (16/43) as good, 34.9%
as satisfactory, and 23.3% (10/43) as poor. Mean satisfaction
scores were 2.04 in the intervention group and 2.76 in control
group. There was a significantly higher mean satisfaction in the
intervention group (t85=4.60, P<.001).
Discussion
Principal Findings
This study compared the effectiveness of a Web-based
intervention in reducing depressive symptoms and sickness
absence among adults with immediate risk for sickness absence
due to mild to moderate depression. When compared with a
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wait-list plus psycho-education control group, participants who
used the Web-based intervention showed a significantly greater
reduction in depressive symptoms. However, because of the
low response and high attrition in this study, one primary
outcome did not reach statistical significance among participants
who completed the intervention (per-protocol analysis) and at
follow-up, only within-group changes were sustained but the
intervention effect was not. In terms of individual clinical
significance, significantly more participants in the intervention
group responded to the treatment. We used health insurance
records to measure sickness absence and found that sickness
absenteeism declined in both groups, but there were no statistical
differences in work absence between groups. The achieved
power of this trial was lower than calculated. Therefore, its
results should be replicated in a larger sample.
Comparison With Prior Work
These findings are especially relevant when considering the
increasing impact of mental ill-health on workforces across
industrialized countries [55]. Depression is a significant cause
for workday losses and produces more absence durations than
other mental illnesses. To reduce the illness burden, widespread
access to evidence-based treatment is needed to maintain
workers’ mental health before companies and individuals face
more serious burdens as the illness progresses. In general,
Web-based interventions provide a promising treatment tool
because these interventions can be accessed at any time and at
different locations at the users’ own pace. Due to their relative
anonymity, Web-based interventions may especially benefit
employees with depression who wish to avoid the negative
perceptions of being mentally ill in the workplace. However,
risks associated with the dissemination of Web-based
interventions in the health care system have been reported as
well. According to meta-analysis, the effects of Web-based
interventions vary, making it necessary to evaluate each
intervention separately. If Web-based interventions that are
effective in reducing depressive symptoms are more widely
implemented and adopted, a positive impact on the burden and
impairment caused by depression can be expected. It can also
help to overcome the shortcomings of conventional treatment
(eg, waiting lists).
This study contributes to the growing body of research that
supports the effectiveness of Web-based interventions for
depression. Within this research, a critical mass of efficacy
studies is needed to identify subgroups for which these
interventions work [56]. Adults who are at high risk for sick
leave from work due to mild to moderate depression have not
yet been targeted specifically by Web-based interventions. In
terms of effect sizes, previous research has found significant
heterogeneity between studies. This makes it necessary to
evaluate each intervention separately. The effect sizes reported
in this study are comparable to other studies evaluating guided
interventions for depression, including those included in the
meta-analysis by Andersson and Cuijpers [23] where a mean
between-group effect size of d=0.41 is reported. The amount
of therapy guidance that is necessary to increase intervention
effectiveness and adherence remains a subject of debate in the
field of Web-based interventions [18,57]. Considering that this
intervention provided only minimal therapist support upon
request and achieved similar outcomes to studies with more
intense guidance, we speculate that merely having the option
to contact a therapist during the intervention—versus regular
therapist contact—is sufficient for the needs of many participants
and works equally well. However, it is possible that the number
of dropouts could have been reduced with regular guidance.
The examination of support preferences was not within the
scope of this study and further research on this subject is needed.
We found that health insurance records are a suitable outcome
for effectiveness research in Web-based interventions. Both
groups showed reductions in work absence frequency, however,
no statistical difference in work absence between groups was
found. Several explanations may account for this finding. First,
we cannot rule out the possibility that the decline in work
absence frequency over time was caused by regression toward
the mean or spontaneous remission. Our sample was recruited
during a period of high levels of sickness absence, as seen in
the data (see Table 3). Consequently, due to statistical chance,
the frequency of sickness absence tended to approach lower
levels at post-assessment. A healthy control group is needed to
compare baseline levels of sickness absence, which was
unavailable in this study. Second, it is possible that the 90-day
time period in our study was not sufficiently long to
appropriately detect changes in work absence. Previous
population studies on sickness absence due to mental health
problems found a median absence duration of 79 days [58]. This
indicates that sickness absence started or ended outside of the
time period of this study. Similarly, our sample was not
adequately powered to detect small differences in work loss
days. Third, organizational factors (ie, high work demands, job
security) could have influenced work absence in this study.
Unfortunately, we could not measure organizational variables.
To disentangle these explanations, future studies on the effect
of Web-based interventions on work absence should include a
longer time period, information on organizational factors that
may be related to sickness absence, and work absence data from
a healthy control group for baseline comparisons. Integrating
objective behavioral parameters (ie, sickness absence data from
health insurance companies) can increase the validity of
effectiveness studies and might be a valuable addition to
self-reported outcome measurements.
Privacy and Data Security
In Web-based interventions, health-related information is
processed and stored electronically. Therefore, data security
and confidentiality issues need to be taken seriously. This study
used several measures to ensure the privacy of the study
participants. Person-related information and study data were
stored on separate servers to ensure that individuals could not
be identified. Communication between the users’ Web browsers
and the servers were encrypted via a Secure Sockets Layer (SSL)
connection. All data were stored on servers located in Germany.
Limitations
There are several limitations to this study that must be
acknowledged. First, although reporting the effect of the
Web-based intervention was within the scope of our study, it
remains unclear as to which specific elements and properties of
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the intervention contributed to its effectiveness. Regarding the
length of the intervention, evidence on the dose-response
relationship in psychotherapy points to the conclusion that most
progress occurs in the first few sessions of an intervention [59].
Similarly, Web-based interventions with 8 or less sessions were
found to be more effective than interventions with more than 8
sessions [21]. This indicates that the present intervention with
its 12 sessions could be shortened in length while maintaining
its effectiveness.
A second limitation concerns the response rate. Response from
the pool of positively screened insurance members was low
(5.8%, 226/3929). This raises the concern that participants were
particularly motivated to use a Web-based intervention when
compared with nonparticipants, especially because
nonparticipants were positively screened for sickness absence
due to depression and thus belonged to the target group. Ideally,
data from nonparticipants should have been collected as a
baseline comparison group, but this data was unavailable in this
study because of a lack of informed consent. When the complete
pool of insurance members was screened and all positively
screened insurance members were invited, recruitment was
stopped. This resulted in a substantially smaller sample than
was previously calculated in the power analysis (calculated
N=680 vs actual N=180).
Third, attrition during the study was high. At post-assessment,
45.5% of the participants had dropped out, and at follow-up,
67.7% of participants had dropped out. In general, dropout is a
common problem in Web-based interventions [60]. However,
the dropout in this study was remarkably higher than the average
attrition rate for Web-based interventions with therapist support,
as reported in the meta-analysis by Richards and Richardson
(28%) [21]. Several recent studies on Web-based interventions
showed dropout rates that were remarkably lower [27,32]. One
possibility for the relatively high attrition in this study is that
participants who failed to complete a weekly session were
reminded via email only. Comparable studies, which used
telephone reminders, achieved substantially higher participant
compliance. A second explanation is that therapist guidance
was available upon request only. Guided interventions have
lower attrition rates as compared to unguided interventions.
Thus, it is possible that participants who were at risk for dropout
were less likely to use therapist guidance. Despite our analysis
of per protocol and imputed data showing comparable results,
which indicates no difference in intervention completers versus
noncompleters, the risk remains that study dropout could have
biased the results. Due to the associations of several baseline
characteristics (age, education, and being in psychotherapy)
with the likelihood to complete the outcome assessments, the
missing at random assumption could have been violated. Overall,
the high attrition rates limit the conclusions drawn from this
study.
Third, the positive relationship of age and education with study
dropout seen here limits the generalizability of the findings to
younger and less educated groups. This is supported by the
composition of the study sample, where highly educated
participants and those in executive positions are
over-represented. Further studies with more statistical power
are needed to identify effectiveness among different subgroups.
Fourth, participants had access to treatment as usual during the
study, including psychotherapy and medication. Therefore we
cannot exclude the possibility that within-group changes in
depression scores were affected by third factor variables. Thus,
within-group changes must be interpreted with caution.
Fifth, no clinical interviews were conducted to assess depression.
Structured clinical interviews represent the gold standard of
clinical assessment, with superior validity and reliability. Due
to limited resources, this study relied solely on participants’
self-reports to assess clinical symptoms.
Sixth, the amount and duration of provided therapeutic support
during the study was not measured, making it difficult to
compare the results with other studies on Web-based
interventions that have used different levels of support, ranging
from no support to more intensive and regular support. In this
study, support was provided upon request, which could have
prevented some participants from using support, thus lowering
adherence.
Seventh, we used a wait-list plus psycho-education control
group. Wait-list control groups undermine internal validity and
may lead to an over-estimation of the treatment effect [24].
Thus, active control groups are considered to be less biased. To
maximize participant response, we decided to inform control
group participants that they could access the intervention upon
request after study completion. This may have lowered
expectations with regard to the control condition. Furthermore,
control group participants were active during the study period
as they had access to psycho-education. As a result, we observed
mean symptom reductions in the control group, which is
consistent with the finding that Web-based psycho-education
can reduce depressive symptoms [41]. At the same time, it is
possible that psycho-education has adverse effects in some
participants, because it sensitizes patients to the topic of
depression, leading to an over-reporting of symptom severity
at follow-up. For example, a study that used a psycho-education
control group found that the incidence of depression was higher
than usual [32]. Our results show that reliable symptom
deterioration was low overall, but occurred more frequently in
the control group (6.25%, 5/80) as compared with the
intervention group (1%, 1/100). This suggests that adverse
effects in the control groups were present, but were unlikely to
bias the treatment effect. As we did not collect data on usage
and engagement with the psycho-education in the control
condition, the perceived credibility of the psycho-education
remains unknown.
Eighth, this was an open-label trial, where participants and
researchers were aware of which group was receiving which
treatment. Furthermore, only questionnaire data was assessed
as a proxy of use parameters, but no uptake data was available
on the actual usage of the program (eg, frequency and length
of website usage). Data on how the participants interacted with
the program could provide valuable insights into the
effectiveness of specific intervention elements.
Conclusions
The Web-based intervention reduced depressive symptoms
among adults with sickness absence. As this trial achieved a
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lower power than calculated, its results should be replicated in
a larger sample. Further validation of health insurance records
as an outcome measure for eHealth trials is needed.
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